CSIMarket
 
Ionis Pharmaceuticals Inc   (NASDAQ: IONS)
 

IONS's Market share relative to its competitors, as of Q2 2026

As of Q2 2026 (Revenue in Millions of $)

Date modified: 2026-08-14T10:06:37+00:00





COMPANY NAME REVENUES
12 Months Ending
Q2 2026
MARKET SHARE
12 Months
Q2 2026
MARKET SHARE
MRQ
Q2 2026
MARKET SHARE
A Quarter Before
Q1 2026
Ionis Pharmaceuticals Inc 822.43 0.69% 0.92 % 0.88 %
Pfizer Inc 63,315.00 52.76% 51.68% 51.80%
Regeneron Pharmaceuticals Inc 14,919.60 12.43% 12.39% 13.92%
Vertex Pharmaceuticals Inc 12,218.00 10.18% 11.46% 10.71%
Grifols Sa 8,426.88 7.02% 7.02% 0.00%
Alnylam Pharmaceuticals Inc 4,286.92 3.57% 4.01% 3.93%
62 more competitors available

Sign in to see all competitors for Ionis Pharmaceuticals Inc .




IONS's Market share relative to its competitors, as of Q2 2026 within the Major Pharmaceutical Preparations Industry
As of Q2 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2026
MARKET SHARE
12 Months Ending
Q1 2026
MARKET SHARE
MRQ
Q2 2026
MARKET SHARE

Q1 2026
Ionis Pharmaceuticals Inc 0.70% 0.61% 0.93 % 0.90 %
Pfizer Inc 53.77% 54.76% 51.97% 52.58%
Regeneron Pharmaceuticals Inc 12.67% 12.55% 12.46% 14.13%
Vertex Pharmaceuticals Inc 10.38% 10.50% 11.52% 10.87%
Grifols Sa 7.16% 7.07% 7.16% 7.07%
Alnylam Pharmaceuticals Inc 3.64% 3.25% 4.03% 3.99%
56 more companies available

Sign in to see all industry competitors for Ionis Pharmaceuticals Inc .




IONS's Market share relative to its competitors, as of Q2 2026 within the Healthcare Sector
As of Q2 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2026
MARKET SHARE
12 Months Ending
Q1 2026
MARKET SHARE
MRQ
Q2 2026
MARKET SHARE

Q1 2026
Ionis Pharmaceuticals Inc 0.69% 0.60% 0.92 % 0.88 %
Pfizer Inc 52.76% 53.83% 51.68% 51.80%
Regeneron Pharmaceuticals Inc 12.43% 12.34% 12.39% 13.92%
Vertex Pharmaceuticals Inc 10.18% 10.32% 11.46% 10.71%
Grifols Sa 7.02% 6.95% 7.02% 6.95%
Alnylam Pharmaceuticals Inc 3.57% 3.19% 4.01% 3.93%
62 more companies available

Sign in to see all sector competitors for Ionis Pharmaceuticals Inc .




Note: Market share is calculated based on total revenue. To get a more accurate picture of Ionis Pharmaceuticals Inc's market divisions, geographic dispersion, segments, products, and services, visit Ionis Pharmaceuticals Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.